By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.

Monthly Archives: April 2016

Diabetes quality outcome workshop launches

28th April 2016

The first practical and interactive national workshop focusing on driving quality outcomes in diabetes care will take place in June. The Association of British Clinical Diabetologists (ABCD) ...

Read more

JDRF announces £97m research funding

27th April 2016

A total of £97m will be spend on tackling diabetes in the UK, it has been announced. The money is being provided by seven funders, the type 1 charity JDRF said in a report called Type 1 Research ...

Read more

Date for APPG diabetes summit announced

26th April 2016

The date for the next All Party Parliamentary Group for Diabetes meeting has been announced. The Diabetes Innovation Summit will take place on Thursday, October 27 and will take place in ...

Read more

Unknown diabetes molecule identified

26th April 2016

Scientists have solved an immune system mystery relating to type 1 diabetes, which could help develop new ways to prevent and treat the disease. Researchers from the University of Lincoln ...

Read more

Shoe shop raises amputation awareness

26th April 2016

A temporary shoe shop in London has helped raise awareness of the 135 diabetes-related amputations which take place in England every week. Each weekly amputation was represented by a pair of ...

Read more

Mindset linked to poor foot ulcer outcome

22nd April 2016

The mindset of people with diabetic foot ulcers about their illness has a significant effect on their survival, new research has suggested. The five year study looked at the heath outcome of 169 ...

Read more

Gut hormone could be key to type 2 remission

21st April 2016

Scientists have found the factor which puts type 2 diabetes into remission following bariatric surgery, according to new research.  Researchers have identified the gut hormone PYY plays a key ...

Read more

First oral GLP-1 results unveiled

21st April 2016

The first oral glucagon-like peptide 1 receptor agonist (GLP-1) has shown promising results in treating type 2 diabetes. Data revealed at the Keystone Symposia on New Therapeutics for Diabetes ...

Read more